TWD
BNTC icon

True Wealth Design’s Benitec Biopharma BNTC Stock Holding History

True Wealth Design’s Portfolio BNTC Stock Details BNTC Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$308 Buy
23
+22
+2,200% +$261 ﹤0.01% 2345
2026
Q1 		$11 Buy
+1
New +$12 ﹤0.01% 2663

Other funds holding BNTC

SAM
Simplify Asset Management Las Vegas, Nevada $7.19B AUM 6.88% 1-Year Est. Return
GI
GAMMA Investing Foster City, California $2.69B AUM 42.78% 1-Year Est. Return
FFA
Farther Finance Advisors San Francisco, California $12.8B AUM 26.53% 1-Year Est. Return

True Wealth Design's BNTC Position: Q2 2026 in Review

True Wealth Design increased its Benitec Biopharma (BNTC) stake by 2,200% in Q2 2026, buying an estimated $261 and bringing the position to 23 shares worth $308. The position accounts for ﹤0.01% of the portfolio, ranked #2345.

True Wealth Design first reported a position in BNTC in Q1 2026 and has held it in 2 quarters since. 4 funds tracked by Wall St. Rank hold BNTC as of Q2 2026.

  • True Wealth Design held 23 shares of Benitec Biopharma worth $308 as of Q2 2026.
  • True Wealth Design bought 22 Benitec Biopharma shares in Q2 2026, an estimated $261.
  • Benitec Biopharma made up ﹤0.01% of True Wealth Design's portfolio in Q2 2026, its #2345 holding.
  • True Wealth Design first reported a position in Benitec Biopharma in Q1 2026 and has held it in 2 quarters since.
  • 4 funds tracked by Wall St. Rank held Benitec Biopharma as of Q2 2026.

Based on True Wealth Design's 13F filing for Q2 2026, filed 16 Jul 2026.